Health Histories And Screenings - NAPLEX

Identify problems, assess risk, and guide safe, effective therapy. This purpose ensures pharmacists can detect drug-related issues, evaluate risks, and optimize treatment plans for patient safety and efficacy.

Full name and date of birth (and a second identifier when available). These identifiers prevent errors in documentation and ensure accurate linkage to the correct patient's medical records as per safety standards.

“What brings you in today?”. This open-ended question encourages patients to describe their chief complaint in their own words, facilitating a focused and patient-centered history.

Onset, Provocation/Palliation, Quality, Region/Radiation, Severity, Time. OPQRST provides a structured framework to thoroughly characterize pain or symptoms, aiding in differential diagnosis and treatment decisions.

Drug, reaction description, severity, and timing/onset. Documenting these elements allows for precise risk assessment, differentiation of true allergies, and safe future prescribing decisions.

“What reaction occurred, and how soon after the dose did it start?”. This question captures the nature and timing of the reaction, helping differentiate immune-mediated allergies from non-allergic adverse effects.

Adherence (how the patient actually takes each medication). Assessing adherence reveals discrepancies between prescribed and actual use, enabling accurate interpretation of therapy effectiveness and risks.

OTC drugs, herbals, vitamins/supplements, and PRN products. Including these categories ensures a complete history, identifying potential interactions or contributors to the patient's condition.

Tobacco, alcohol, recreational drugs, diet, and pregnancy intentions. These elements influence drug metabolism, interactions, teratogenicity, and patient education, directly impacting therapeutic choices.

GI bleed/ulcer, CKD, ASCVD risk, anticoagulant use, and pregnancy. Screening for these conditions identifies contraindications to NSAIDs, preventing risks like bleeding, renal injury, or fetal harm.

Uncontrolled hypertension (and significant cardiovascular disease). Decongestants can exacerbate hypertension and cardiovascular risks, making this screening essential to avoid adverse events.

Systolic $130$–$139$ mmHg or diastolic $80$–$89$ mmHg. This threshold, per ACC/AHA guidelines, identifies early hypertension for timely intervention and cardiovascular risk reduction.

Seated, back supported, feet flat, arm at heart level, correct cuff size. This positioning minimizes measurement errors, ensuring reliable blood pressure readings for accurate hypertension screening.

Fasting plasma glucose at least $126$ mg/dL. Per ADA criteria, this value confirms hyperglycemia consistent with diabetes, guiding further evaluation and management.

$A^1c$ at least $6.5%$. ADA guidelines establish this threshold as indicative of chronic hyperglycemia, supporting diabetes diagnosis in screening.

Random plasma glucose at least $200$ mg/dL with symptoms. ADA criteria recognize this level with symptoms like polyuria as diagnostic, prompting immediate diabetes confirmation and treatment.

$BMI = \frac{kg}{m^2}$. This formula standardizes body composition assessment, enabling consistent obesity and health risk evaluation in adults.

$BMI$ $30.0$–$34.9$ kg/m$^2$. WHO classification uses this range to identify moderate obesity, associating it with increased risks for comorbidities like diabetes.

LDL-C (interpreted with overall ASCVD risk and clinical factors). Guidelines prioritize LDL-C levels alongside ASCVD risk scores to determine statin initiation and intensity for primary prevention.

Prior vaccines, dates, reactions, contraindications, and pregnancy/immunocompromise. These elements allow assessment of immunization status, safety, and needs, ensuring appropriate vaccine recommendations.

Sudden “worst headache,” neurologic deficit, or signs of meningitis. These symptoms suggest serious conditions like subarachnoid hemorrhage or infection, necessitating urgent medical intervention over self-treatment.

Difficulty breathing, drooling, or inability to swallow fluids. These signs indicate potential airway compromise or severe infection, requiring prompt medical assessment to prevent complications.

Activate emergency response and refer immediately (call $911$). Chest pain may signal acute cardiac events, so immediate emergency activation ensures rapid evaluation and life-saving intervention.